MolMed
Автор: Alliance for Regenerative Medicine
Загружено: 2019-05-08
Просмотров: 101
Описание:
Luca Alberici, Ph.D., Chief Business Officer
Milan, Italy
(MLM.MI)
MolMed S.p.A. is an Italian biotechnology cell and gene company, focused on research, development, manufacturing and clinical validation of innovative therapies in oncology and rare diseases. MolMed built an original dual business model, based on research and development of proprietary products, and third party GMP services. MolMed is currently the developer and manufacturer for worldwide leaders in the field of gene therapy for rare diseases and allogenic CAR-T therapies supporting their clinical trials and commercial supply. MolMed, founded in 1996 as an academic spin-off of the San Raffaele Scientific Institute, is listed on the main market (MTA) of the Milan stock exchange and has been managed by Borsa Italiana since March 2008. MolMed is headquartered and based in Milan, at the San Raffaele Biotechnology Department and has an operating unit at OpenZone in Bresso.
www.molmed.com
Повторяем попытку...
Доступные форматы для скачивания:
Скачать видео
-
Информация по загрузке:
